Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.75M Buy
19,616
+333
+2% +$90.1K 1.04% 21
2025
Q4
$5.71M Sell
19,283
-777
-4% -$233K 1.28% 17
2025
Q3
$5.66M Sell
20,060
-875
-4% -$229K 1.31% 16
2025
Q2
$6.17M Buy
20,935
+156
+0.8% +$40.2K 1.29% 16
2025
Q1
$5.17M Buy
20,779
+203
+1% +$49.7K 1.13% 19
2024
Q4
$4.52M Sell
20,576
-134
-0.6% -$29.8K 0.99% 23
2024
Q3
$4.58M Buy
20,710
+48
+0.2% +$9.41K 0.99% 21
2024
Q2
$3.57M Buy
20,662
+63
+0.3% +$10.9K 0.83% 28
2024
Q1
$3.93M Sell
20,599
-890
-4% -$162K 0.95% 21
2023
Q4
$3.51M Sell
21,489
-391
-2% -$59.1K 0.97% 23
2023
Q3
$3.07M Buy
21,880
+688
+3% +$97.9K 0.93% 24
2023
Q2
$2.84M Buy
21,192
+527
+3% +$68K 0.87% 26
2023
Q1
$2.71M Buy
20,665
+385
+2% +$51.5K 0.94% 23
2022
Q4
$2.86M Buy
20,280
+557
+3% +$76.8K 1.21% 18
2022
Q3
$2.34M Buy
19,723
+945
+5% +$124K 1.13% 21
2022
Q2
$2.65M Buy
18,778
+467
+3% +$63K 1.18% 19
2022
Q1
$2.38M Buy
18,311
+848
+5% +$111K 0.85% 28
2021
Q4
$2.33M Sell
17,463
-792
-4% -$99.3K 0.91% 26
2021
Q3
$2.42M Buy
+18,255
New +$2.44M 0.94% 19

Other funds holding IBM

Herold Advisors's IBM Position: Q1 2026 in Review

Herold Advisors increased its IBM (IBM) stake by 1.7% in Q1 2026, buying an estimated $90.1K and bringing the position to 19,616 shares worth $4.75M. The position accounts for 1.04% of the portfolio, ranked #21.

Herold Advisors first reported a position in IBM in Q3 2021 and has held it in 19 quarters since. The position peaked at $6.17M in Q2 2025. 3,462 funds tracked by Wall St. Rank hold IBM as of Q1 2026.

  • Herold Advisors held 19,616 shares of IBM worth $4.75M as of Q1 2026.
  • Herold Advisors bought 333 IBM shares in Q1 2026, an estimated $90.1K.
  • IBM made up 1.04% of Herold Advisors's portfolio in Q1 2026, its #21 holding.
  • Herold Advisors first reported a position in IBM in Q3 2021 and has held it in 19 quarters since.
  • Herold Advisors's IBM position peaked at $6.17M in Q2 2025.
  • 3,462 funds tracked by Wall St. Rank held IBM as of Q1 2026.

Based on Herold Advisors's 13F filing for Q1 2026, filed 15 May 2026.